HER2-low Breast Cancer
Oncology
Prevalence
289.8 / 100K
Incidence
30.4 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target HER2-low Breast Cancer?
There are 1 clinical trial targeting HER2-low Breast Cancer tracked by BioSniper.
What is the prevalence of HER2-low Breast Cancer?
The estimated prevalence of HER2-low Breast Cancer is approximately 289.8 per 100,000 population.
Deep-dive into HER2-low Breast Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis